Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Exxon Mobil: A Cash-Generating Industrial with Optionality — Stop Valuing It Like a Commodity Pure-Play
Buy a high-quality integrated operator trading like a cyclical oil name; actionable long with entry, stop, and targets.
Exxon Mobil is more than a barrel-and-spot oil story. With resilient operating cash flow ($14.8B in Q3 2025), a strengthening dividend program, and a ...
Barnes & Noble Education (BNED): Deep Value, Real Cash Flow - 4x EBITDA, Buy the Turnaround
Small market cap, improving operating margins, and an enterprise value near 4x EBITDA creates an asymmetric long opportunity.
Barnes & Noble Education is trading at roughly $8.09 (as of 01/08/2026) with an implied enterprise value around $390M and trailing-12-month EBITDA nea...
Murphy Oil: Buy the Base — Appraisal Win Potential, Cash Flow Support, and an Attractive P/B
A tactical swing-long on MUR after operational de-risking and steady cash generation; entry, stops and targets included.
Murphy Oil (MUR) looks like a tradable long from current levels: the company has recurring operating cash flow, a conservative balance sheet, and a gr...
Invitation Homes - Buy the Political Dip: Income + Cash Flow Meet an Overshot Selloff
Trump-driven headlines pulled INVH into a buying window; fundamentals and a 4%-plus yield make this a tactical long.
Invitation Homes (INVH) dropped ~5% intraday on 01/07/2026 after political headlines about corporate home ownership hit the tape. The balance sheet, o...
Rocket Lab (RKLB) - Set Up for a 2026 Breakout; Trade Plan for the Next Big Wins
Catalyst-rich setup around Neutron progress and growing launch cadence; valuation is expensive today but risk/reward looks attractive on pullbacks.
Rocket Lab has the operational momentum (quarterly revenue up to $155M) and fresh financing to push Neutron development and scale launches in 2026. Th...
Smith & Nephew - Orthopedics Recovery, Undervalued Entry but Knees Remain the Key Risk
Procedure volumes and wound-care tailwinds support a long trade; use tight risk controls around knee-related execution.
Smith & Nephew (SNN) looks like a company moving from cyclical trough to steady recovery. Procedure volume rebounds, favorable end-market growth in wo...
Buy Coherent (COHR) - Optical Networking Is the AI Infrastructure Call Option
A pullback entry into a company riding accelerating AI-driven demand for high-speed optical modules and lasers
Coherent has moved from trough margins to profitable quarters as data-center optical demand ramps. With Q1 FY2026 revenue of $1.58B and net income of ...
Autodesk: Market Expansion + Cleaner Financials Make a Tactical Long
Buy on pullbacks; AI and XR adoption extend the TAM while cash flow and buybacks buttress the risk profile
Autodesk's core design franchises are converting to higher-value, AI-enabled subscription products and new verticals (construction XR, generative desi...
Meta: Strong Rule-of-40, Cheapen On Pullbacks - Buy Idea
Operational profitability + mid-20s revenue growth means buy the dip; actionable entry, stops and targets below.
Meta's latest quarter (ended 09/30/2025) delivered ~26% revenue growth and a ~40% operating margin - a Rule-of-40 score north of 65. That combination ...
CrowdStrike: Betting on a Quiet Network Effect and Margin Inflection
Falcon's telemetry moat is real — price the setup, not the hype
CrowdStrike's cloud-native Falcon platform shows sequential revenue strength, improving operating leverage and robust cash generation. The combination...
Bright Minds (DRUG) - Breakthrough Readout Reprices a Binary Biotech; Buy the Breakout for a Swing Win
Top-line clinical breakthrough (market-moving) plus clear pathway to partnering supports a 'Strong Buy' trade — tactical entry, disciplined stop, asymmetric upside.
Bright Minds Biosciences reported market-moving breakthrough clinical data and the stock has ripped higher — trading near $96 as of 01/07/2026. The ...
Hims & Hers: Cheap Growth in Telehealth — A Tactical Long
Revenue momentum, improving operating cash flow and an outsized rerating opportunity make HIMS a timely swing/position long
Hims & Hers is showing sustained revenue acceleration and positive operating cash flow while the stock trades well below its mid-year highs. With Q3 F...